ADVFN - ニュース

US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/08/03	04 : 27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:TOST	Toast Inc
2024/08/03	04 : 26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:RGEN	Repligen Corp
2024/08/03	04 : 26	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NYSE:BMA	Banco Macro SA
2024/08/03	04 : 26	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:MS-P	Morgan Stanley
2024/08/03	04 : 26	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:JPM-M	JP Morgan Chase and Co
2024/08/03	04 : 26	PR Newswire (US)	American Board of Emergency Medicine Looks to the Future: Appoints Executive Director, Professional and Clinical Affairs
2024/08/03	04 : 25	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:TD	Toronto Dominion Bank
2024/08/03	04 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CINF	Cincinnati Financial Corporation
2024/08/03	04 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CINF	Cincinnati Financial Corporation
2024/08/03	04 : 24	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:VXX	iPath Series B S&P 500 VIX ShortTerm Futures ETN
2024/08/03	04 : 24	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NYSE:SXI	Standex International Corp
2024/08/03	04 : 23	Alliance News	Linde cuts guidance despite second quarter growth	LSE:0M2B	Linde Plc
2024/08/03	04 : 23	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:JPM-M	JP Morgan Chase and Co
2024/08/03	04 : 23	Business Wire	AM Best Assigns Credit Ratings to Auto Club MAPFRE Insurance Company
2024/08/03	04 : 22	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:RLJ-A	RLJ Lodging Trust
2024/08/03	04 : 22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:CTLT	Catalent Inc
2024/08/03	04 : 22	GlobeNewswire Inc.	Ocugen, Inc. Announces Closing of $35 Million Public Offering of Common Stock	NASDAQ:OCGN	Ocugen Inc
2024/08/03	04 : 22	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:GS-J	Goldman Sachs Group Inc
2024/08/03	04 : 22	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	AMEX:UAVS	AgEagle Aerial Systems Inc
2024/08/03	04 : 22	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NYSE:TYL	Tyler Technologies Corp
2024/08/03	04 : 22	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:VXX	iPath Series B S&P 500 VIX ShortTerm Futures ETN
2024/08/03	04 : 22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:TDOC	Teladoc Health Inc
2024/08/03	04 : 21	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:CBKM	Consumers Bancorp Inc (QX)
2024/08/03	04 : 21	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ACCD	Accolade Inc
2024/08/03	04 : 21	PR Newswire (US)	BayCare Hospitals Are Top-Rated
2024/08/03	04 : 20	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:JPM-M	JP Morgan Chase and Co
2024/08/03	04 : 20	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:JPM-M	JP Morgan Chase and Co
2024/08/03	04 : 20	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	AMEX:VXX	iPath Series B S&P 500 VIX ShortTerm Futures ETN
2024/08/03	04 : 19	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NYSE:GS-J	Goldman Sachs Group Inc
2024/08/03	04 : 19	PR Newswire (US)	FDA Roundup: August 2, 2024

1 2 3 4 5 6 7 8 9 10 次へ >>

JP Morgan Chase

US Dollar vs Euro

Invesco QQQ Trust Series 1

American Express

Gold vs US Dollar

Bank of America

BNP Paribas (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約